Summary:
This 4-week, randomized, double-blind, multicenter, placebo-controlled study is designed to compare the safety and efficacy of HP-5000 (HP-5000 is a topical patch placed over the knee and may contain active medicine or placebo) with that of placebo in the treatment of OA.
Qualified Participants Must:
• Healthy male or female aged 40 to 85 years with a clinical diagnosis of OA of the target knee.
•
Have symptoms of OA knee pain for at least 6 months prior to screening.
•
Body mass index (BMI) less than 40.
•
Not have a known allergy or hypersensitivity to non-steroidal anti-inflammatory medications.
•
Willingness to comply with the study follow-up schedule.
Qualified Participants May Receive:
Free medical care, free medical imaging, free medicines and compensation for time and travel.